Ardelyx, Inc. (ARDX) Stock Grade

About Ardelyx, Inc.'s fundamentals

Ardelyx is a biotechnology company with a market capitalization of $1.4 billion that is experiencing strong revenue growth at 22.1% year-over-year. However, the company is currently unprofitable, operating with a negative net margin of -15.1%, and reported a net loss in its latest annual statement. The company does not pay a dividend. Given the company's pre-revenue or early-stage commercialization profile typical of biotechnology firms, traditional profitability metrics like P/E ratio and return on equity are not applicable.